Understanding OUR Cytokine-Based Immunotherapy Candidates Our motivation extends to advancing a robust portfolio of programs aimed toward expanding the horizons of cytokine-based immunotherapy, specifically for cancers where treatment method choices remain limited. Utilize the links below to learn far more about our portfolio of cytokine-based immunotherapy candidates. Explore Our https://financefeeds.com/xs-com-appoints-marios-skitsas-to-lead-product-strategy/